leisure time -WSS

leisure time

author：entertainment 2025-08-23 08:52:55 - browse：996

Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest.

The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans. Nicol spent more than 20 years at the Broad Institute, where he co-founded the MIT-Broad Foundry for Synthetic Biology, as well as HiFiBio Therapeutics and Design Pharmaceuticals.

RA Capital confirmed RASyn’s existence. Senior Managing Director Josh Resnick told STAT it’s part of the firm’s work to rethink how it develops platforms — core technologies or scientific approaches that underpin all of the drugs a biotech develops — but declined to comment further.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Hospitals consider fixing cancer drug shortages on their own

leisure time

knowledge

WSS

Food makers tried to stack nutrition panel with preferred experts

How medical schools plan to diversify without affirmative action

Roche’s Alnylam deal shows drug firms interested in heart drugs

Roche’s Alnylam deal shows drug firms interested in heart drugs

In the gardens at Boston Children's Hospital, families find sanctuary

Hospitals consider fixing cancer drug shortages on their own

focus

leisure time

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

PEPFAR is under serious threat — and so is global health

Hepatitis C has a cure — but many Americans still lack access to it

Will the FTC rein in IQVIA's health data empire?

ChatGPT in medicine: STAT answers readers' burning questions

How medical schools plan to diversify without affirmative action

Activists slam private health insurers over coverage restrictions

New Covid vaccine is recommended for everyone 6 months or older

DIEP, the 'gold standard' of breast reconstruction, is under threat

Pig kidney works a record two months in donated body

focus

Roche’s Alnylam deal shows drug firms interested in heart drugs

White House touts steps to stem shortages of cancer treatments

Will the FTC rein in IQVIA's health data empire?

'Investigate these claims': UFO transparency at center of House hearing

Senate panel puts off hardest PBM reforms for another day

FDA proposes changes to key medical devices approval pathway

leisure time

hotspot

knowledge

explore